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Nonadherence to psychotropic medications among patients with serious and persistent 
psychiatric disorders, including bipolar disorder and schizophrenia, is approximately 
70%. Nonadherence is a common barrier to the treatment of individuals with mental 
health disorders. However, there is limited awareness of evidence-based interventions 
and strategies to address this problem. Therefore, the question for this project asks 
whether a systematic review can identify strategies to improve adherence of psychotropic 
medications among individuals with serious and persistent mental illness. The purpose of 
this systematic review was to explore the evidence-based strategies that can aid in 
increasing medication adherence in patients with mental health disease. Sources of 
evidence included online databases such as Walden University Library, PubMed, 
Cochrane Collaboration, PsychINFO, ProQuest, EBSCOHost, Google Scholar, and 
Joanna Briggs Institute. The health belief model provided foundation for this project by 
supporting awareness and self-efficacy of medication adherence.  Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses was used to analyze the evidence. 
Findings revealed that a healthcare staff collaborated education approach targeted toward 
the patient or to the patient and family members was the most effective strategy to 
support medication adherence.  Other evidence-based interventions such as home-based 
physical exercise programs, cognitive-behavioral and motivational strategies, blister 
packaging, financial incentives, and cost sharing were also found to improve adherence. 
This systematic review elicits positive social change in practice by facilitating adherence 
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Section 1: Nature of the Project 
Introduction 
Medication nonadherence is a significant challenge for psychiatric clinicians because it 
increases the possibility of complications and readmissions, thus, increasing healthcare 
expenditure for patients with serious and persistent mental illness (SPMI; Cutler et al., 2018). 
Nonadherence to psychotropic medications takes place at the initial, implementation, and 
persistent stages of clinical therapy for this population (Torres-Robles et al., 2018). The Centers 
for Disease Control and Prevention (CDC) has also identified medication nonadherence as a 
global problem, especially in long-term therapies (Neiman et al., 2017). Nonadherence to 
psychotropic medications has also been associated with various adverse outcomes, including 
suicidal tendencies, deterioration of prognosis, and lower quality of life among psychiatric 
patients (Cutler et al., 2018). For example, nonadherence is linked to mortality, violence, and 
hospital readmission among patients with schizophrenia (Steinkamp et al., 2019; Torres-Robles 
et al., 2018).  
Medication nonadherence among individuals with mood disorders such as bipolar 
disorder and major depressive disorder has also been linked with slower initial recovery, high 
suicide risk, and hospitalizations (Jawad, Watson, Haddad, Talbot, & McAllister-Williams, 
2018; Steinkamp et al., 2019). These studies highlight the importance of medication adherence 
across various mental health disorders.  
The advent of more effective psychotropic medications has ushered in an era in the 
management and treatment of SPMI, improving the ability of many patients to live 




patients with mental health disorders have to take all medications and therapies as prescribed by 
their clinicians (Montejo et al., 2018). Studies have indicated that nonadherence to psychotropic 
medications can result from socioeconomic-, treatment, condition, patient, and health system-
related factors (Cutler et al., 2018; Semahegn et al., 2018; Steinkamp et al., 2019; Torres-Robles 
et al., 2018). Mental health disorders pose significant challenges for patients, making it difficult 
to adhere to prescribed medications (Cutler et al., 2018).  
In this systematic review, I sought to identify evidence-based strategies that are employed 
to improve medication adherence among patients with SPMI. This project has the potential to 
identify positive social changes in practice that could increase adherence to psychotropic 
medication therapies, improving quality of life, and decreasing hospitalization. 
Problem Statement 
 Despite the ability of psychotropic medications to minimize the severity of mental health 
disorders, many patients still abandon prescribed medications prematurely (Montejo et al., 2018). 
The prevalence of medication nonadherence among mental health patients is considerably high 
and varies based on disorders (Semahegn et al., 2018). For patients with schizophrenia, 
nonadherence rates range from 41-50%, while for those with depression, it is between 13% and 
52% (Steinkamp et al., 2019). Also, individuals with opioid dependence and anxiety disorders 
have nonadherence rates of 68% and 57%, respectively (Steinkamp et al., 2019). According to 
Chakrabarti (2016), the rate of medication nonadherence among patients with mental health 
conditions could reach 70%. These statistics provide a glimpse of how severely the problem of 




In the United States, hospitalizations resulting from medication nonadherence cost over 
$100 billion every year (Shafrin et al., 2017). In addition, the annual cost of nonadherence to 
psychotropic medications among patients with mental health illnesses is approximately $1.5 
billion (Shafrin et al., 2017). A recent study by Cutler et al. (2018) also indicated that the 
estimated cost of nonadherence to psychotropic medication is $3,252-$19,363 for every patient. 
Given that about 46.6 million adults in the United States are affected by mental health disorders 
annually, there is a need for more effective interventions to improve medication adherence in this 
population (Substance Abuse and Mental Health Services Administration [SAHMSA], 2017). 
These figures highlight the extent of nonadherence to prescribed treatment regimen aimed at 
managing psychotic symptoms among patients with SPMI. 
According to Harrison, Kats, Williams, and Aziz-Zadeh (2019), persistence or 
maintaining adherence to psychotropic medications is difficult, and the nonadherence rate 
worsens over time. Nonadherence to psychotropic medications is a significant challenge because 
it increases the patients’ risk of readmission, suicide, and deterioration, and reduces their quality 
of life (Borba et al., 2018). Research has indicated that nonadherence can also affect the patients’ 
health negatively; thus, increasing the overall healthcare costs for managing mental health 
disorders (Cutler et al., 2018; Joe & Lee, 2016). In addition, some patients with SPMI lack 
adequate support and access to medications, and others have a misconception about the 
effectiveness of antipsychotics, which increases the likelihood of nonadherence (El-Mallakh & 
Findlay, 2015). Therefore, there is a need for psychiatric facilities to adopt new and more 




 Over the past few decades, health practitioners have been trying to address the problem 
of medication nonadherence by designing various educational, therapeutic, technological, and 
pharmacological interventions (Martin, Feig, Maksoudian, Wysong, & Faasse, 2018). An 
increase in awareness of the most effective strategies for improving adherence to psychotropic 
medications can be applied in practice to improve patient outcomes (Jawad et al., 2018). 
Reducing nonadherence can reduce morbidity and minimize the cost of care for mental health 
patients, thus decreasing the burden for families and psychiatric facilities (Cutler et al., 2018; Joe 
& Lee, 2016; Rao, George, Sudarshan, & Begum, 2017) 
Purpose 
The purpose of this systematic review was to explore the evidence-based strategies that 
can aid in increasing medication adherence in mentally ill patients. The guiding practice-focused 
question was, “What evidence-based strategies can be implemented by healthcare providers to 
improve adherence to antipsychotics among individuals with SPMI?” There is a gap in the 
literature regarding evidence on the improvement of medication adherence among patients with 
mental health disorders (Kleinsinger, 2018). The project has the potential to address the gap-in-
practice relating to the most effective strategies and interventions for improving adherence to 
antipsychotics among individuals with SPMI. The systematic review facilitated the synthesis of 
relevant evidence regarding the most effective strategies for improving medication adherence 
among patients with SPMI.  
Nature of the Doctoral Project 
 For this project, I employed a systematic review design to explore the most recent and 




patients with SPMI. The rationale behind the use of a systematic review design is because of its 
principles of replicability, rigor, and transparency that increase the strength and quality of 
evidence (Booth, 2016). 
Viswanathan et al. (2018) indicated that systematic reviews are reliable because they 
facilitate broader research while maintaining focus on empirical evidence as opposed to 
preconceived knowledge of a given problem. A primary advantage of systematic reviews is that 
they help in reducing implicit researcher bias by employing broad literature search strategies, 
uniform inclusion-exclusion criteria, and predefined search terms (Booth, 2016). Additionally, 
systematic reviews facilitate the careful evaluation of research problems and questions from the 
onset, including the analysis of interventions, populations, associated comparisons, and findings 
(Sturm & Sunyaev, 2019). The focus improves the investigators’ likelihood of addressing the 
research questions more objectively and clearly (Viswanathan et al., 2018).  
The primary sources of evidence included peer-reviewed studies on evidence-based 
strategies for improving medication adherence among patients with SPMI. The studies were 
obtained through a comprehensive literature search on reliable online databases, including 
Walden University Library, Cochrane Collaboration, PubMed, PsychINFO, EBSCOHost, 
ProQuest, Google Scholar, and Joanna Briggs Institute.  
 Systematic reviews have various benefits over traditional literature reviews. For example, 
the investigators’ increased focus is an advantage over traditional literature reviews, which are 
based on results from previous research without consideration of the study design, analytical 
methods, data collection, sample size, and data (Sturm & Sunyaev, 2019). In addition, systematic 




Synthesizing information on the research designs, causality, and analytical methods used in the 
selected studies allowed the DNP student to evaluate the robustness and reliability of the 
collected evidence (Booth, 2016). Systematic reviews are also more reliable compared to 
traditional literature reviews because they follow a clear protocol that guides the investigator 
throughout the project and improves transparency (Munn et al., 2018).  
However, the systematic review design also has several limitations that could influence 
the quality of the findings (Munn et al., 2018). For example, systematic reviews are sophisticated 
and require access to several databases and peer-reviewed studies, which can be challenging and 
expensive for students (Sturm & Sunyaev, 2019). Another potential limitation of systematic 
reviews is that literature searches on institutional databases can undermine the objectivity and 
introduce bias (Munn et al., 2018). As indicated by Viswanathan et al. (2018), the search strings 
in different databases can be discarded or adapted altogether because the websites are designed 
using specific search functions. As a result, investigators can miss a potentially large number of 
relevant studies.  
 The inclusion-exclusion criteria of systematic reviews may also introduce bias during 
screening and may result in research team members having different interpretations (Sturm & 
Sunyaev, 2019). According to Munn et al. (2018), systematic reviews have a high likelihood of 
subjectivity when screening studies and when a large project team is involved. Because every 
team member interprets the inclusion-exclusion criteria differently, there is a high likelihood of 
subjectivity that may negatively influence the findings (Sturm & Sunyaev, 2019). In addition, 
systematic reviews are affected by resource and time constraints, which can be another source of 




research on effective evidence-based strategies for improving adherence among patients with 
SPMI. It was anticipated that the findings of this systematic review would improve the 
understanding of evidence-based practices for improving adherence to psychotropic medication 
among SPMI patients and improve their health outcomes.   
Significance of the Project 
 Nonadherence to psychotropic medications is a significant public health problem in the 
United States. Recent studies have associated nonadherence to psychotropic medications with 
increased recidivism and emergency department visits, higher costs of care, and higher mortality 
rates among individuals with mental health disorders (Cutler et al., 2018; Goldstone et al., 2015; 
Joe & Lee, 2016). Adherence to psychotropic medication is an essential concern, especially for 
patients with severe mental health issues, including bipolar disorder, schizophrenia, and 
posttraumatic stress disorder (Penninx & Lange, 2018). Wide variations in nonadherence rates 
among individuals with SPMI have been reported over the recent past. For example, Fiszdon, 
Kurtz, Choi, Bell, and Martino (2015) found that the adherence rates for schizophrenic 
individuals ranged from 25-75%. However, a similar study by Ibrahim, Yahya, Pindar, Wakil, 
Garkuwa, and Sale (2015) indicated that the adherence rate for the same population is 
approximately 50%.  
The significance of the systematic review is based on the need to explore the problem of 
medication nonadherence among patients with mental health disorders in the United States. 
Recent statistics indicate that clinicians report cases of nonadherence for up to 70% of the mental 
health patients (Chakrabarti, 2016). The systematic review improved the understanding of the 




this systematic review could significantly influence mental patients’ outcomes if applied in 
practice. In addition, the insight provided by the findings of this systematic review could 
influence the type of strategies employed by psychiatric clinicians to improve medication 
adherence among patients with mental disorders. The systematic review also has the potential to 
elicit positive social change in practice by facilitating improvement in adherence to psychotropic 
medications; thus, reducing hospitalization and comorbidity. The systematic review could have a 
significant influence on all stakeholders in psychiatric care facilities by introducing change in 
medication adherence among patients with SPMI. Improved medication adherence would reduce 
hospitalizations among patients with mental illnesses such as bipolar disorder and schizophrenia 
(Steinkamp et al., 2019). The systematic review would facilitate the synthesis of evidence-based 
strategies for improving adherence among patients with SPMI.  
The systematic review can facilitate a positive change in practice by enhancing 
psychiatric clinicians’ understanding of evidence-based strategies for improving adherence to 
psychotropic medications among patients with SPMI. As a result, clinicians can educate patients 
and implement the most appropriate interventions to each patient; thus, enhancing patient 
outcomes (Borba et al., 2018). The systematic review also has the potential to introduce positive 
change in practice by improving adherence to psychotropic medications, hence decreasing the 
risk of comorbidities and subsequently reducing healthcare costs for adult individuals with 
mental health disorders (Borba et al., 2018). Improved health outcomes among psychiatric 






Despite the effectiveness of psychotropic medications in reducing the symptoms of 
psychiatric disorders, a large proportion of mental health patients still fail to fully comply with 
prescribed regimens (Steinkamp et al., 2019). Estimates indicate that nonadherence to 
psychotropic medications among individuals with mental health disorders can reach up to 70%, 
highlighting the need for effective evidence-based practices to address the problem (Chakrabarti, 
2016). The purpose of this systematic review was to explore the evidence-based strategies that 
can aid in increasing medication adherence in mentally ill patients. 
This section has provided a comprehensive overview of the background of the problem 
involving nonadherence to psychiatric medication among adults with SPMI. The guiding 
practice-focused question was, “What evidence-based strategies can be implemented by 
healthcare providers to improve adherence to antipsychotics among individuals with SPMI?” A 
systematic review was conducted to synthesize the most relevant and recent evidence on 
strategies for improving adherence to psychotropic medications among adult patients with SPMI. 
The benefits of using a systematic review design include enhanced objectivity and transparency, 
broader literature search, and minimization of the chance of implicit researcher bias (Ahn & 
Kang, 2018). Findings from this systematic review are significant because they can improve 
awareness of evidence-based strategies for improving medication adherence among patients with 
SPMI. An increase in adherence would improve the patients’ health outcomes, improve their 
quality of life, and reduce the healthcare burden of this population on their family and psychiatric 
institutions (Jawad et al., 2018). The systematic review also has the potential to effect positive 




frequency of rehospitalizations. Section 2 presents a comprehensive review of the background 
and context of the problem, the Iowa model of evidence-based practice, the relevance of the 
systematic review to nursing practice, and the role of the DNP student. 
Section 2: Background and Context 
Introduction 
Nonadherence to psychotropic medications is a serious public health issue in the United 
States because of its consequences for the patients, their family members, and the healthcare 
sector (Gebeyehu et al., 2019). As a result, various evidence-based interventions have been 
adopted to help improve mental health patients’ adherence to prescribed medications (Costa et 
al., 2015). The purpose of this systematic review was to explore the evidence-based strategies 
that can aid in increasing medication adherence among individuals with SPMI. Despite the 
effectiveness of psychotropic medications in reducing the severity of mental health disorders, the 
majority of mentally ill patients still fail to optimally adhere to prescribed drugs (Montejo et al., 
2018). The prevalence of medication nonadherence in mentally ill patients is significantly high 
despite the implementation of various therapeutic, pharmacological, educational, and 
technological interventions by health practitioners (Martin et al., 2018). There is also a lack of 
adequate literature on the most effective strategies for improving adherence among individuals 
with SPMI. The goal of conducting this systematic review was to address the practice-focused 
question, “What evidence-based strategies can be implemented by healthcare providers to 
improve adherence to antipsychotics among individuals with SPMI?”  
This section involves a discussion of the concepts, models, and theories relevant to the 




I describe the relevance of the systematic review of nursing practice and how the findings could 
be applied to improve health outcomes among patients with SPMI. Section 2 provides 
background of the problem of nonadherence to psychotropic medications in the United States 
and explains the role of the DNP student in the systematic review.  
Concepts, Models, and Theories 
 Nonadherence to prescribed psychotropic medications is among the major behavioral risk 
factors among individuals with SPMI (Cutler et al., 2018). Nonadherence to psychotropic 
medications is usually common among patients with low socioeconomic statuses, minorities, and 
those from communities with scarce resources (Torres-Robles et al., 2018). Patients with SPMI 
need appropriate and timely behavioral modification and long-term maintenance to avoid 
deterioration and adverse complications that may even lead to death (Borba et al., 2018). Thus, 
the theoretical foundation of the current systematic review was based on Becker’s (1974) health 
belief model (HBM) to help improve the understanding of the importance of adherence to 
psychotropic medications among individuals with SPMI.  
The HBM 
The HBM was developed by psychologists in the 1950s with the goal of improving the 
use of preventive programs by the public (Becker, 1974). The model is based on six concepts, 
including perceived susceptibility, perceived benefits, perceived usefulness, cues to action, 
perceived barriers, and self-efficacy (Jones et al., 2015).  
 Perceived susceptibility involves people’s beliefs regarding the likelihood of contracting 
a disease or condition (Jeihooni, Hidarnia, Kaveh, Hajizadeh, & Askari, 2016). The effectiveness 




dependent on how individuals perceive the consequences and risk of SPMI in their lives (Jones 
et al., 2015). Improving the understanding of evidence-based strategies for increasing medication 
adherence in mental healthcare is important among individuals with SPMI as it reduces the risk 
of complications and adverse health outcomes. Conducting a systematic review of the evidence-
based strategies for improving adherence to psychotropic medications would improve awareness 
of the negative health outcomes resulting from the deterioration of patients’ conditions.  
 Perceived barriers refer to people’s beliefs regarding the psychological and tangible costs 
of the interventions or actions (Jones et al., 2015). Thus, the patients’ participation in improving 
their behaviors is inhibited by physical, psychosocial, or financial barriers (Jeihooni et al., 2016). 
Individuals with SPMI are faced with various barriers in their desire to maintain optimal 
adherence to psychotropic medications, including lack of adequate knowledge, health illiteracy, 
and financial issues. The systematic review could provide ideas on evidence-based interventions 
for improving adherence that is less susceptible to some barriers.  
 Perceived benefits involve people’s beliefs about the efficacy of the interventions to 
minimize the severity of the impacts (Jeihooni et al., 2016). An individual’s perception of 
engaging in health-promoting behavior influences the risk of severity and susceptibility (Jones et 
al., 2015). To control SPMI and prevent complications resulting from nonadherence, individuals 
suffering from these conditions must adopt effective evidence-based interventions. Thus, it is 
essential to synthesize high-quality empirical evidence on evidence-based strategies for 
improving medication adherence among individuals with SPMI.  
 Cues to action or triggers to health-related behavioral change are influenced by people’s 




or both (Jeihooni et al., 2016). I applied this concept in the systematic review to identify 
strategies that allow providers to identify and address the causes or triggers of nonadherence 
behaviors among mental health patients. A potential strategy could be improving mental health 
patients’ knowledge of the importance of adhering to psychotropic medications.  
 Self-efficacy involves individuals’ confidence in their ability to act towards changing 
their health behaviors (Jones et al., 2015). With adequate information on evidence-based 
strategies, individuals with SPMI would develop confidence in their ability to maintain and take 
their medications as prescribed by psychiatrists (Jeihooni et al., 2016). This systematic review 
added to the existing body of literature on evidence-based strategies for improving adherence 
among individuals with SPMI. Individuals with SPMI may share information from the 
systematic review with others in society. This review may enhance the understanding of different 
evidence-based strategies for preventing nonadherence among SPMI patients. For example, 
providers would have an increased knowledge of provider-targeted strategies, such as training 
and education. Additionally, the systematic review can enhance providers’ experience of patient-
targeted strategies such as compliance therapies, cognitive-behavioral therapy, and motivational 
interviewing (Kondo et al., 2015).  
 The HBM is suitable for this systematic review because it provides a foundation for 
improving awareness of the importance of adherence to psychotropic medications among 
individuals with SPMI. The evidence-based interventions that were the focus of this systematic 
review involved strategies for reducing nonadherence to psychotropic medications. The HBM 





The Iowa Model   
Titler et al.’s (2001) Iowa model is mainly used to translate empirical evidence into 
practice to improve care quality. The Iowa model is comprised of seven primary steps that 
describe the collection of relevant data to provided evidence on a given problem. The Iowa 
model can help psychiatric clinicians and other practitioners to apply research findings into 
practice to improve patient outcomes.  
The first stage of the Iowa model aims to identify a knowledge-based or problem-focused 
trigger that necessitates evidence-based practice change (Brown, 2014). Knowledge-based 
triggers occur when new research findings are produced or when there is a need for new practice 
guidelines. Conversely, problem-based triggers involve the identification of clinical problems or 
arise from risk management information and financial data (White & Spruce, 2015). It has been 
documented that nonadherence to psychotropic medications is a major problem in the United 
States, with significant impacts on patients, their families, and the health industry in general 
(Steinkamp et al., 2019). In this stage, the team determines whether the target problem is a 
priority. As indicated by White and Spruce (2015), organizations are more likely to prioritize 
problems with higher costs or those that are voluminous. 
The second step in the model involves the formation of a team to develop, implement, 
and evaluate evidence-based practice change. According to Lloyd, D’errico, and Bristol (2016), 
the composition of the team is dependent on the problem and should preferably include 
interdisciplinary stakeholders. The team should be interested and preferably include internal and 




The third step involves collecting and analyzing research related to the identified problem 
and practice change (White & Spruce, 2015). This stage includes the formation of appropriate 
research questions and searching for literature on related studies. In addition, the investigator is 
required to collect and review existing studies on the target clinical problem.   
The fourth stage involves the critiquing and synthesis of evidence gathered during the 
literature search (White & Spruce, 2015). In this step, the team reviews the collected research to 
critically appraise the evidence. The appraisal process is aimed at determining whether there is 
adequate high-quality evidence to address the research questions.  
The fifth step involves the synthesis of evidence and making recommendations for 
clinical practice (Brown, 2014). If there is adequate evidence, the change is implemented.  
The sixth step involves the implementation of the systematic review after approval and 
ensuring that all the procedures and policies are consistent with organizational guidelines (Lloyd 
et al., 2016). The establishment of an effective communication plan for disseminating the 
findings is essential. The findings can be disseminated using posters, manuscripts, and 
presentations in conferences and workshops.  
The final step involves evaluating whether the change is feasible and if the results can 
improve patient outcomes (Lloyd et al., 2016). The evaluation phase yields feedback on the 
systematic review that allows for revisions if needed. The selected studies were evaluated to 
determine whether there was adequate high-quality evidence on evidence-based strategies for 
improving adherence among SPMI patients.  
The Iowa models provided clear frameworks for performing the systematic review. The 




practice. Medication nonadherence among individuals with SPMI is a major problem in the 
United States that needs to be addressed to improve health outcomes and minimize health care 
expenditure on this population. Conducting a systematic review is a positive step in identifying 
effective evidence-based strategies for improving medication adherence among SPMI patients.  











Medication adherence: Medication adherence involves the extent to which an 
individual’s behavior corresponds with care providers’ recommendations and prescriptions 
McQuaid & Landier, 2018).  
Systematic review: A systematic review is a study that summarizes the findings of 
existing healthcare research that provides highly reliable evidence on the effectiveness of 
specific strategies or interventions (Robinson & Lowe, 2015).  
Antipsychotic: Antipsychotic medications are treatments for addressing delusions, 
hallucinations, and manic symptoms in the short-term (Martino, Karnik, Osland, Barnes, & 
Pringsheim, 2018).  
Evidence-based interventions: Evidence-based interventions refer to peer-reviewed 
strategies, programs, or practices that are published in the empirical literature of effectiveness 
(Hailemariam et al., 2019). 
Serious and persistent, mentally ill. SPMI comprises severe mental health disorders, 
including schizophrenia, bipolar disorder, borderline personality disorder, and major depression 
(Kinter, 2017). 
Relevance to Nursing Practice 
There is an increase in the rate of nonadherence among individuals with SPMI in the 
United States (Torres-Robles et al., 2018). Mental health disorders affect over 46 million adult 
Americans annually (National Institute of Mental Health [NIMH], 2019). Although psychotropic 




deterioration among psychiatric patients, nonadherence is still prevalent in this population 
(Torres-Robles et al., 2018).  
Nonadherence to psychotropic medications has been linked to various factors, including 
socioeconomic status, stigma, substance abuse disorder, care fragmentation, cultural influences, 
psychopathology, issues relating to treatment, and lack of awareness (Phan, 2016; Steinkamp et 
al., 2019). The growing prevalence of nonadherence among individuals with SPMI results in 
increased financial burden on healthcare institutions, families, and the society in general (Joe & 
Lee, 2016; Rao et al., 2017). In addition, various studies indicate that noncompliance with 
prescribed psychotropic medications is a significant driver of suboptimal health outcomes among 
individuals with mental health issues (Borba et al., 2018; Cutler et al., 2018; Steinkamp et al., 
2019). As indicated by Jawad et al., (2018), nonadherence to psychotropic medications can have 
significant negative impacts on patients because it can cause suicidal tendencies, relapse, delayed 
remission, and readmission.  
 The purpose of psychotropic medications among individuals with SPMI is to manage 
symptoms and reduce the risk of relapse, suicidal tendencies, readmission, and longer remission 
times (Borba et al., 2018). Implementing interventions that aid in promoting medication 
adherence among individuals with SPMI can positively impact health outcomes and the society. 
Lack of knowledge and insight of evidence-based strategies for improving adherence to 
psychotropic medications has been identified as a major contributor of nonadherence (Phan, 
2016). Studies have suggested various behavioral and psychoeducational interventions for 
minimizing the prevalence of nonadherence among individuals with SPMI (Borba et al., 2018; 




knowledge of evidence-based strategies for improving medication adherence among individuals 
with SPMI. Increase in clinicians’ knowledge and understanding of these interventions could 
translate into improved patient outcomes.   
Current State of Adherence to Psychotropic Medication 
Nonadherence to psychotropic medications continues to be a significant problem among 
adult Americans who have SPMI; thus, clinicians need to apply their expertise to identify and 
design effective interventions to address the problem (Semahegn et al., 2018). This systematic 
review investigated effective evidence-based strategies that can be implemented to increase 
adherence to psychotropic medication among individuals with SPMI. The systematic review has 
the potential to improve psychiatric clinicians’ awareness of the most appropriate and effective 
interventions for improving adherence to psychotropic medications among patients with SPMI. 
The systematic review facilitated the synthesis of the knowledge from the latest and most 
relevant peer-reviewed evidence. An increase in awareness of evidence-based strategies for 
improving adherence can be translated into practice to help improve clinical outcomes among 
patients with SPMI. Consequently, an increase in adherence to psychotropic medications would 
reduce the likelihood of readmission and minimize healthcare costs; thus, decreasing the 
financial burden of this population. The standard practice for addressing nonadherence to 
psychotropic medication involves designing a treatment plan that is consistent with the patients’ 
rehabilitation and recovery (Galletly et al., 2016). Over the past three decades, new psychotropic 
drugs have been consistently supplied to clinicians to treat the various mental health disorders 
(Lister, 2016). The U.S. Food and Drug Administration has approved nine antidepressant agents, 




et al., 2018). Recent empirical evidence indicates the effectiveness of various interventions in 
improving medication adherence rates among adult patients with mental health issues 
(Steinkamp et al., 2019). For instance, a recent study by Hughes, Vess, and Johnson (2018) 
demonstrated the effectiveness of motivational adherence therapy in improving adherence to 
psychotropic medications among veterans living with severe mental illnesses. After 
implementing Motivational Interviewing Style Adherence Therapy (MISAT), Hughes et al. 
(2018) found a clinically significant improvement in the participants’ adherence to psychotropic 
medications. In addition, there was an increase in the participants' average refill history by 3% 
(Hughes et al., 2018).  
A study by Trujillo (2015) also indicated that mobile reminder applications and coaching 
sessions could effectively increase adherence to psychotropic medication among adult patients 
with SPMI. The study included 15 participants and indicated a significant increase in the 
participants’ medication adherence rates after two months. A similar study by Spoelstra, 
Schueller, Hilton, and Ridenour (2015) also supported the effectiveness of cognitive-behavioral 
interventions and motivational interviewing in improving adherence to psychotropic 
medications. Spoelstra et al. (2015) concluded that a combination of motivational interviewing 
and cognitive-behavioral interventions could effectively improve medication adherence among 
patients with SPMI. 
Though the nonadherence rate among mental health patients differed nationwide because 
of varying definitions and measurements, it is estimated that about 13-56% of all individuals 
with psychiatric illnesses do not comply with prescribed medication regimen (De Las Cuevas, de 




mental health illness has been found to vary based on the condition. For example, the rate of 
nonadherence among schizophrenia patients is approximately 50-61%, while for those with 
bipolar disorder, the noncompliance rate varies from 20-60% (De Las Cuevas et al., 2017). 
Nonadherence to Psychotropic Medications 
 Nonadherence to psychotropic medications is a significant predictor of adverse health 
outcomes for mental health patients, including rehospitalization, suicide, relapse, premature 
death, delays in remission, and aggression (Steinkamp et al., 2019). In addition, the positive 
association has been found between nonadherence to psychotropic medications and healthcare 
costs for mental health disorders with higher noncompliance rates causing higher treatment costs 
(Cutler et al., 2018). The availability of psychotropic medications has improved with drugs 
playing a significant role in the treatment of patients with severe psychiatric illness (Smith et al., 
2017).   
 Effective management of mental health disorders involves various complex medication 
regimens that require a daily intake of multiple drug combinations (Smith et al., 2017). The high 
rate of nonadherence to psychotropic medications among adults is associated with various 
patient, systemic, and environmental factors (Gebeyehu et al., 2019). However, no factor can 
thoroughly explain the reasons for nonadherence among adult patients with SPMI. For example, 
older adults with mental health issues are predisposed to medication nonadherence by deficits in 
cognitive processes, which impair their ability to plan and manage the intake of psychotropic 
drugs effectively (Smith et al., 2017). Other reasons for nonadherence to psychotropic 
medications include poor insight, stigma, distressing side effects, negative attitudes towards 




 In a recent study, Novick et al. (2015) found that increased baseline insight and an 
improved therapeutic alliance was associated with higher adherence to psychotropic medications. 
Therapeutic alliance involves the partnership and cooperation between mental health patients and 
healthcare professionals to achieve improved outcomes (Novick et al., 2015). Conversely, insight 
involves individuals’ awareness of their psychological condition (Novick et al., 2015). Insight 
The primary goal of the study was to evaluate the relationship between medication adherence 
and medication insight among 903 schizophrenic adult patients. The study was observational and 
set in Europe, focusing on adherence to oral olanzapine medication over 12-months. The 
participants used the Scale to Assess Unawareness of Mental Disorder, Global Assessment of 
Functioning, Working Alliance of Functioning, Working Alliance Inventory, Medication 
Adherence Rating Scale, and Clinical Global Impression. The results indicated that patients with 
schizophrenia had a significantly lower insight and higher unawareness compared to those with 
bipolar disorder (p < 0.001). The authors also found a significant association between higher 
adherence to psychotropic medications and improved insight (p < 0.0001). Besides, there was a 
strong relationship between a stronger therapeutic alliance and higher insight (p< 0.0001). 
Novick et al. (2015) concluded that insight has a significant-close relationship with adherence to 
psychotropic medication. 
 A recent systematic review by Smith et al. (2017) explored the association between 
nonadherence with various domains among individuals with cognitive impairment and dementia. 
The authors indicated that the adherence rates in most of the studies ranged from 10.7% to 38%, 
with individuals not suffering from cognitive impairment having better compliance rates. 




al. highlighted that executive functioning, memory, and new learning was linked to improved 
adherence to psychotropic medications. The authors concluded that there is a gap in knowledge 
of some domains may contribute to medication nonadherence among mental health patients with 
SPMI. 
Strategies for Improving Medication Adherence 
 Investigators have designed various interventions that can be implemented to improve 
adherence to psychotropic medications. For example, El-Mallakh and Findlay conducted a 
review to evaluate interventions, notably support service, employed by clinicians to improve 
medication adherence among schizophrenia patients. The study involved a comprehensive 
review of the literature published over ten years period from CINAHL, Medline, PubMed 
databases. The key terms used in the study included “support services,” “medication adherence,” 
and “schizophrenia.” Based on the findings, 22 studies focused on support-service strategies, 
including financial incentives, adherence therapy, cognitive-behavioral and motivational 
strategies, and technological interventions such as the use of electronic reminders through 
telephones or text messages. El-Mallakh and Findlay indicated that interventions involving 
support services should be adapted to address the specific needs of patients with schizophrenia. 
In addition, El-Mallakh and Findlay recommended further investigation of effective support-
service interventions that can be applied to enhance long-term medication adherence among 
patients with mental illness.   
 Moran and Priebe (2016) also conducted a randomized controlled trial to evaluate how 
financial incentives influence the intake of psychotropic medications. The study involved a 




encourage intake of antipsychotic medications and a control group who received no incentives. 
Compared to the control, the intervention group demonstrated improved adherence and better 
quality of life. There was an estimated 19.59 % (SD = 17, 52 %) average increase in the 
participants’ adherence to antipsychotic medications. The regression model indicated that 
improvement in adherence to psychotropic medications significantly predicted increased 
subjective quality of life (p < 0.014). Moran and Priebe concluded that adherence to anti-
psychotropic medication is associated with improved quality of life; thus, the need for clinical 
relevance for improved adherence resulting from financial incentives.  
 Kondo et al. (2015) also conducted a qualitative study exploring interventions aimed at 
improving adherence to pharmacological medications among patients with bipolar disorder, 
psychotic spectrum disorders, and posttraumatic stress disorder. The authors indicated that there 
are various interventions for improving pharmacological adherence and are focused on patients, 
providers, ad organizations. Patient-targeted interventions are mainly behavioral and 
psychosocial and may include motivational interviewing, cognitive-behavioral therapy, 
customized adherence enhancement, shared decision-making, and adherence and compliance 
therapies. Conversely, provider-targeted interventions include training and education on 
motivational interviewing. Organizational level interventions include financial incentives, care 
coordination, blister packaging, and minimizing economic barriers through cost-sharing. Other 
organizational level interventions for improving medication adherence include communication 
technologies such as short message service (SMS), refill reminders, and e-monitoring.   
 Kreyenbuhl, Record, and Palmer-Bacon (2016) conducted a study to evaluate the 




with severe mental disorders. Kreyenbuhl, et al. identified the need for effective behavioral 
interventions for improving adherence to help 60% of patients who do not take medications as 
prescribed. Some of the non-technology-based behavioral interventions included environmental 
supports in the individuals’ homes such as Cognitive adaptation training (CAT), pharmacy-based 
and telephone reminders, and financial incentives (Kreyenbuhl et al. 2016). Conversely, 
technology-based behavioral interventions for improving adherence included computerized 
relational agents and electronic medication monitors. 
 Pauly et al. (2015) conducted a prospective clinical trial to evaluate the effects of an 
inter-sectoral and multi-dimensional intervention on medication adherence among patients with 
mental illnesses. The multi-dimensional component in the intervention included individualized 
patient education and therapy simplification, while the inter-sectoral aspect involved subsequent 
phone calls post-discharge. The study involved 269 patients from a hospital setting in Germany, 
who were grouped into control and intervention groups. The authors measured the participants’ 
adherence using the Drug Attitude Inventory (DAI) and the Medication Adherence Report Scale 
(MARS). The MARS and DAI were used to measure the participants’ adherence and attitudes 
towards drugs, respectively. The results indicated an increase in the patients’ MARS and DAI 
scores three months post-discharge by 1.33 and 1.93 points, respectively. Pauly et al. concluded 
that inter-sectoral and multi-dimensional interventions could significantly increase medication 
adherence among patients with mental health issues.  
 Steinkemp et al. (2019) also conducted an extensive systematic review to evaluate the 
technological interventions employed by clinicians to improve medication adherence among 




the Cochrane Central Register of Controlled Trials, MEDLINE, PsycINFO, EMBASE, Web of 
Science, ClinicalTrials.gov, and Engineering Village were critically appraised to provide reliable 
evidence for the study. The findings indicated that most technological interventions involve the 
integration of reminders, data feedback, contingency management, support messages, care team 
contact abilities, secure medication storage, psychoeducation, and social support engagement 
(Steinkamp et al., 2019). The authors found that the main strategies for measuring adherence 
include remote direct visualization, pill counts, biosensors, self-reports, automated compute 
algorithms, ingestible sensors, and utilization measures. The intervention modalities applied 
include mobile phone apps, interactive voice response, SMS, and websites (Steinkamp et al., 
2019). The authors concluded that the majority of technology-based interventions for monitoring 
and improving medication adherence among mental health patients could also be applied to other 
disorders. 
 A recent focus group by Blixen et al. (2018) evaluated how participation in a tailored 
mental health intervention influences medication adherence among patients with hypertension 
and bipolar disorder. The study involved 13 participants and focused on the facilitators and 
perceived barriers of adherence to bipolar disorder and hypertension adherence and feedback 
relating to the use of a bidirectional SMS system for medication reminders. The results indicated 
that the most common barrier to medication adherence was mood fluctuations. The participants’ 
feedback on the effectiveness of the SMS system in improving medication adherence for bipolar 
disorder was positive. Blixen et al. concluded that the implementation of mental health could 





Local Background and Context 
 The current project was focused on the Stats of Texas. According to the National 
Alliance on Mental Illness (NAMI; 2019), about 19%, representing one in five, adult Americans 
experienced at least one psychiatric illness in 2018. Of this population, about 4.6% experienced 
severe mental illnesses. Statistics also indicate that approximately 3.7% of adult Americans 
experience co-occurring psychiatric disorders annually (NAMI, 2019). The adult population 
affected by mental health disorders in Texas is relatively consistent with the national prevalence, 
with over 5 million Texas having mental health illnesses, which necessitate appropriate 
psychotropic medications (Mental Health Texas, 2019). Of this figure, approximately 2 million 
have persistent or severe psychiatric disorders such as major depression, bipolar disorder, and 
schizophrenia (Mental Health Texas, 2019). 
Psychiatric disorders account for approximately 14% of the disease burden and have 
significantly increased over the past decade (Torres-Robles et al., 2018). In the United States, 
over 46.6 million adults aged 18 years and over have a mental health issue (NIMH, 2019). This 
population depends on psychotropic medications and therapy to manage their conditions and 
achieve improved health outcomes and quality of life (Borba et al., 2018). However, the 
uncertainty surrounding the adherence to psychotropic medications has led to mixed results on 
the effectiveness of treatment (Torres-Robles et al., 2018). Studies indicate that mental health 
patients can only get full benefits of psychotropic medications if they reasonably adhere to the 
prescribed treatment regimens and therapy (Borba et al., 2018). The World Health Organization 
(WHO) estimates that only half of patients with chronic conditions adhere to recommended 




States, the rate of nonadherence to psychotropic medications among patients with mental health 
is approximately 70% (Chakrabarti, 2016). However, some researchers provide varying 
estimates because of the different data collection and measurement methods (Velligan, Sajatovic, 
Hatch, Kramata, & Docherty, 2017).  
Statistics indicate that the cost of nonadherence per patient ranges between $3,252 and 
$19,363 (Cutler et al., 2018). With approximately 46.6 million American adults who have mental 
illness annually, there is a need for effective interventions to address nonadherence among this 
population (NIMH, 2019). As highlighted by Kleinsinger (2018), there is a gap in the literature 
on the improvement of medication adherence among mental health patients. The systematic 
review addressed this gap by exploring the evidence-based strategies that can enhance mental 
health patients’ adherence to psychiatric medications and regimens.   
Medication nonadherence is a crucial barrier to positive health outcomes among patients 
with mental health disorders, including schizophrenia, depression, and bipolar disorders (Borba 
et al., 2018; Cutler et al., 2018). Various studies have indicated that suboptimal adherence to 
psychotropic medications can lead to relapse, low life satisfaction, increased suicidal tendencies, 
poor mental functioning, more rehospitalizations, and increased visits to the emergency 
department (Cutler et al., 2018; Steinkamp et al., 2019; Velligan et al., 2017). However, there is 
a high rate of nonadherence to psychotropic medications in the United States, with statistics 
varying from 10-77% (Cutler et al., 2018). Some researchers have also established that 
nonadherence to psychotropic medication is caused by limited awareness or insight, short illness 
duration, negative attitudes towards medications, substance abuse, lack of family support, and 




who are discharged relapse and are readmitted (Donisi, Tedeschi, Wahlbeck, Haaramo, & 
Amaddeo, 2016). Other factors that have been linked to suboptimal adherence to psychotropic 
medications include reduced medication efficacy, personality traits, prescribers’ characteristics, 
medication unavailability, long home-hospital distance, spirituality, preference for alternative 
and complementary medications, adverse drug reactions, and displeasure with treatment (Borba 
et al., 2018; Iseselo & Ambikile, 2017).  
Because of the high rate of nonadherence to psychotropic medications among mental 
health patients and severe consequences, various interventions have been introduced and 
implemented to help address this problem (Martin et al., 2018). Medication adherence 
interventions for individuals with psychiatric disorders include and not limited to cognitive 
behavioral therapy, adherence and compliance therapies, technological interventions, behavioral 
and psychosocial strategies, and shared decision-making (D’Rozario, Galgut, & Bartlett, 2016). 
Interventions focusing on clinicians and family members have also been found to be effective in 
improving adherence to psychotropic medications among individuals with psychiatric disorders 
(El-Mallakh & Findlay, 2015). Medication adherence interventions targeting psychiatric 
clinicians include training and education on motivational interviewing (Dobber et al., 2018). 
Conversely, interventions targeted at the psychiatric facilities include financial incentives, 
installation of electronic reminder systems, phone follow-up, communication technology 
strategies, adoption of e-Health, and reducing potential economic barriers (WHO, 2019).  
 Adherence to psychotropic medication is dependent on various factors, which are mainly 
related to the patients’ environment, community setting, socioeconomic status, medications, and 




adherent to psychotropic medication compared to those who live below the federal poverty 
threshold (Miasso et al., 2016). African Americans and Latinos have also been found to have 
lower adherence to psychotropic mediations compared to their White counterparts (Lê Cook et 
al., 2017). In addition, patients with major psychiatric conditions have a higher likelihood of 
nonadherence compared to those with less severe disorders (Semahegn et al., 2018). Homeless 
patients and those without insurance coverage also have a high risk of nonadherence to 
psychotropic medications (Rezansoff, Moniruzzaman, Fazel, Procyshyn, & Somers, 2016). The 
prevailing regulatory environment also plays a significant role in promoting adherence among 
patients with SPMI. Some states have adopted aggressive regulations such as Kendra’s Law in 
New York State, which allows for mandatory treatment of SPMI; thus, improving adherence 
rates. California and Michigan also have similar laws in “Laura’s Law” and “Kevin’s Law,” 
respectively that facilitate a form of assisted outpatient treatment for individuals with mental 
health issues (Swartz, Bhattacharya, Robertson, & Swanson, 2017). Under these preventive 
outpatient commitment laws, mental health patients can be ordered to involuntary outpatient civil 
commitment (OPC). This is if their conditions (a) would worsen if not treated, (b) impaired their 
ability to adhere to treatment regimens, or (c) increase the risk of physical harm to themselves 
and others if not treated (Saya et al., 2019).  
Role of the DNP Student 
There has been an increase in the rate of nonadherence to psychotropic medication 
among patients with mental health disorders over the past few decades (Torres-Robles et al., 
2018). For this systematic review, I conducted a comprehensive systematic review of the 




among adults with mental disorders. As the DNP student, I was tasked with performing all the 
phases of the systematic review. In addition to seeking approval from Walden University’s 
institutional review board (IRB), I developed a literature search plan to collect relevant primary 
studies on effective evidence-based strategies for promoting adherence to psychotropic 
medications. I also conducted the literature search in reliable online databases and retrieved the 
studies into a personal database. I then used the retrieved articles to synthesize relevant and 
current evidence-based interventions for promoting adherence. I then provided recommendations 
based on the findings and develop plans for dissemination. The motivation to pursue this 
systematic review was to improve awareness of evidence-based practices for improving 
medication adherence among patients SPMI. 
Various aspects can cause biased consideration of the systematic review’s research 
questions. Though bias is highly prevalent in published studies, their prejudices should be 
carefully considered to ensure ethical design and implementation of a project (Noble & Smith, 
2015). A potential bias in this systematic review may result in the subjective inclusion of studies 
in the systematic review. However, this bias can be avoided by using a strict inclusion-exclusion 
criterion.  
Summary 
The purpose of this systematic review was to explore the evidence-based strategies that 
can aid in increasing medication adherence in mentally ill patients. This section has provided an 
overview of the background and context of nonadherence among mental health patients, a brief 
description of the Iowa Model of evidence-based practice, the relevance of the systematic review 




facilitate the evaluation and translation of empirical evidence into practice in order to improve 
care quality. The Iowa model of evidence-based practice facilitated the identification of problem-
focused and knowledge-based triggers for nonadherence among mental health patients. In 
addition, the Iowa model allowed the DNP student to determine whether the identified problem 
is a priority and create a team to help in the implementation and evaluation of the systematic 
review. Thus, I was able to develop research questions and conduct a comprehensive literature 
search.  
The HBM is used to help improve the understanding of the importance of adherence to 
psychotropic medications among individuals with SPMI. The focus of the systematic review 
included studies on evidence-based interventions for improving adherence to psychotropic 
medications among individuals with SPMI. The HBM model also helped in synthesizing 
evidence involving the individuals’ beliefs and cultural backgrounds in relation to the evidence-
based strategies.  
Mental health issues affect approximately 47 million adult Americans (NIMH, 2019). 
Approximately two million Americans experience severe or persistent or psychiatric disorders, 
including schizophrenia, major depression, and bipolar disorder (Mental Health Texas, 2019). 
Medication nonadherence has been linked to various negative health outcomes, including 
relapse, suicidal tendencies, and even death (Cutler et al., 2018). Nonadherence to psychotropic 
medications is still a major issue affecting individuals with SPMI (Semahegn et al., 2018). 
However, the implementation of system-, provider-, and patient-targeted interventions can 




After conducting the literature search, I critiqued and synthesized evidence from the 
selected studies and determined the feasibility of the proposed change. The systematic review 
has significant implications for nursing practice, especially in reducing the rate of nonadherence 
and improving health outcomes. The systematic review was expected to improve the 
understanding of evidence-based strategies for reducing medication nonadherence among adult 
patients with mental health disorders. Reducing nonadherence to psychotropic medications can 
minimize the rate of adverse health outcomes among patients with psychiatric illnesses, 
including suicidal tendencies, relapse, and even death (Steinkamp et al., 2019).  
 The systematic review could also improve the understanding of evidence-based strategies 
that can be adopted to reduce the barriers to optimal adherence to psychotropic medications, 
including substance abuse disorder, cultural influences, and lack of awareness (Phan, 2016). The 
systematic review has the potential to address the gap in the literature on evidence-based 
interventions that can be implemented to improve adherence to psychotropic medications.  I 
played a significant role in the systematic review, including seeking IRB approval, data 
collection, literature search and synthesis, and evaluation. I also developed various 
recommendations for change in practice aimed at improving adherence to psychotropic 
medications. Section 3 presents a comprehensive discussion of the methods that were used to 








Section 3: Collection and Analysis of Evidence 
Introduction 
Nonadherence to psychotropic medications has been a significant public health issue in 
the United States for the past few decades (Semahegn et al., 2018). Given that mental health 
disorders affect approximately 46.6 million Americans, there is a need to identify the most 
effective interventions for addressing the problem of nonadherence (SAHMSA, 2017). The lack 
of valid and reliable evidence regarding the most effective medication adherence interventions 
for mental health patients makes it difficult for stakeholders to adopt these strategies (Torres-
Robles et al., 2018). The purpose of this systematic review was to explore the evidence-based 
strategies that can aid in increasing medication adherence in mentally ill patients. The target 
problem was the high rate of medication nonadherence among individuals with SPMI. There is 
also a lack of adequate evidence of effective strategies for improving adherence among 
individuals with mental health disorders. This section provides a comprehensive discussion of 
the practice-focused question that guided the systematic review, sources of evidence, and the 
process of analyzing and synthesizing evidence from the systematic review. 
Practice-Focused Question 
The number of adult Americans with mental health disorders who do not adhere to their 
psychotropic medications’ regime is alarming. Previous studies have indicated that nonadherence 
to psychotropic medications can cause adverse health outcomes increasing the cost of health care 
and the rate of rehospitalization of mental health patients (Joe & Lee, 2016; Steinkamp et al., 
2019). There is a gap in literature relating to evidence-based strategies for promoting adherence 




Barlati, 2019). This project was, therefore, aimed at conducting a systematic review of current 
and relevant evidence to summarize existing evidence-based strategies for improving adherence 
to psychotropic medications among adult mental health patients. The guiding practice-focused 
question was, “What evidence-based strategies can be implemented by healthcare providers to 
improve adherence to antipsychotics among individuals with serious and persistent mental health 
issues?” The question was addressed using evidence from the systematic review of current and 
relevant studies on evidence-based strategies for promoting adherence to psychotropic 
medications. The approach of this project included a systematic review of recent studies on 
effective evidence-based interventions for promoting adherence to psychotropic medications 
among adult individuals with mental health disorders. I used reliable online databases such as 
Google Scholar, PubMed, and EBSCOHost. 
Sources of Evidence 
The sources of evidence include journal articles from online databases, including Walden 
University Library, PubMed, Cochrane Collaboration, EBSCOHost, PsychINFO, ProQuest, 
Joanna Briggs Institute, and Google Scholar. For this systematic review, I focused on primary 
studies relating to evidence-based strategies that are used to improve medication adherence 
among patients with mental.  
The literature search strategy and appraisal of collected studies facilitated the synthesis of 
high-quality evidence to address the practice-focused question. As recommended by Booth 
(2016), I conducted the literature search process for this systematic review in five stages: (a) 
formulation of the research question, (b) collection and classification of evidence, (c) critical 




Step 1: Research Question 
The practice-focused question was, “What evidence-based strategies can be implemented 
by healthcare providers to improve adherence to antipsychotics among individuals with serious 
and persistent mental health issues?” The practice-focused question is essential because it 
focuses on the scope of the systematic review of evidence-based interventions for promoting 
adherence to psychotropic medications among mental health patients. The systematic review had 
minimal risk because it did not include human participants; thus, there was no need for 
adherence to associated ethical considerations (Noble & Smith, 2015). Before conducting the 
systematic review, I sought authorization from the Walden University IRB. All the ethical 
concerns involving copyright were followed by appropriately citing all journal articles used in 
the systematic review.  
Step 2: Collection and Classification of Evidence 
 The second step involved the collection and categorization of collected evidence using a 
comprehensive literature search strategy (Booth, 2016). The literature search strategy was 
conducted transparently to ensure that the studies can be evaluated appropriately and facilitate 
future reproduction (Viswanathan et al., 2018). I conducted a comprehensive literature search to 
ensure the inclusion of the most relevant studies while also minimizing the likelihood of 
selection bias.  
The literature search involved locating previous studies conducted to evaluate evidence-
based strategies for promoting adherence to psychotropic medications among adult mental health 
patients. The primary keywords used in the literature search include intervention, evidence-




of keywords to minimize the scope of the systematic review. I also employed Medical Subject 
Headings (MeSH) to refine the literature search further. The scope of the systematic review 
involved studies on evidence-based interventions for improving medication adherence among 
psychiatric patients published over the past 5 years. The primary sources of literature I focused 
on were peer-reviewed clinical journal articles. Despite using keywords, I found that the 
literature search to yielded studies that extend beyond the scope of the systematic review and 
research questions. The search was further refined using an inclusion-exclusion criterion. The 
inclusion criteria included selecting only articles that (a) were published between 2015 and 2019, 
(b) are peer-reviewed, (c) involve evidence-based interventions for promoting adherence to 
psychotropic medications, and (d) are published in English. The exclusion criteria include the 
elimination of studies that (a) were published later than 2015, (b) are not peer-reviewed, (c) do 
not involve evidence-based interventions for promoting adherence to psychotropic medications, 
and (d) are not published in English. The literature search strategy was applied with supervision 
from experts at Walden University 
The selection process first involved screening the abstracts and titles of the studies to 
ensure that they met the inclusion-exclusion criteria before accessing the full texts. After reading 
the titles and abstracts of the studies, I selected those sources that appeared to satisfy the 
inclusion-exclusion criteria. From these studies, I identified studies that contain evidence-based 
practices for improving medication adherence to psychotropic medication. I maintained accurate 
documentation of relevant studies throughout the literature search process, including the total 
number of results yielded by every combination of keywords and those that were excluded. The 




St ep 3: Critical Appraisal 
 The third step involved the critiquing of every selected study to produce evidence for 
addressing the research question (Booth, 2016). A critical appraisal also allowed for evaluation 
of the validity and applicability of the relevant studies to practice and future research. I first 
evaluated the quality of the selected primary studies. The studies were critically appraised for 
credibility, validity, and reliability 
Step 4: Evidence Synthesis 
After critically appraising the selected primary studies, I summarized the evidence to 
provide a comprehensive overview of the quality and essential findings. I focused on the 
methodology, sample size, and primary findings of the studies. The evidence was arranged in the 
form of universal themes from the primary findings of the selected studies.   
Step 5: Presentation of Limitations and Recommendations 
The final step involved a detailed presentation of the limitations of the evidence and the 
recommendations. The limitations allowed stakeholders to evaluate the strengths of the evidence 
while also considering potential weaknesses. Based on the findings of the review, I presented 
recommendations for practice, future research, theory, and policy. 
The literature search focused on peer-reviewed primary studies published over the past 5 
years, between 2014 and 2019. The studies needed to involve evidence-based strategies that have 
been employed to improve adherence to medications among patients with mental health 
disorders. The journal articles which must be published in English were critically appraised to 
synthesize the most reliable evidence on effective strategies for improving medication adherence 




Headings (MeSH) to refine the literature search. I also accessed statistics on medication 
adherence from reliable websites such as the WHO, National Mental Health Association 
(NMHA), the American Psychiatric Association, the NAMI, the American College of Sports 
Medicine, and the SAMHSA. The systematic review was aimed at addressing the gap in the 
literature on evidence-based strategies that can be adopted to increase medication adherence 
among mental health patients. Conducting the systematic review provided reliable evidence on 
the most effective strategies for improving medication adherence and health outcomes among 
patients with SPMI.  
Analysis and Synthesis 
The literature search was conducted exhaustively with strict adherence to the inclusion 
and exclusion criteria. I recorded the total number of articles yielded by every search 
combination while also documenting studies that did not meet the inclusion criteria. The 
resulting journal articles were critically evaluated to synthesize evidence supporting 
interventions for promoting adherence among mental health patients with SPMI. I also aimed to 
develop various recommendations based on the findings of the literature search.  
The journal articles were organized and ranked using the Preferred Reporting Items for 
Systematic reviews and Meta-Analyses (PRISMA) method (Selçuk, 2019). The primary 
keywords included intervention, nonadherence, evidence-based, and psychotropic medication. 
The literature search involved various combinations in reducing the scope and producing the 
most relevant studies. Evidence collected from the selected studies were used to develop reliable 
recommendations for the implementation of evidence-based strategies to improve adherence to 




The analysis process mainly involved the documentation of the online databases, the 
literature search strategy, abstraction of relevant content from selected studies, and detailed 
synthesis of findings from the studies. The analysis procedures involved the evaluation of the 
evidence from the selected studies in relation to their strength of evidence. The entire systemic 
review followed the Iowa and HBM. The Iowa model mainly guided the translation of empirical 
evidence into practice to improve medication adherence among individuals with SPMI. 
Conversely, the HBM helps in improving the awareness of the perceived benefits and usefulness 
of medication adherence among individuals with SPMI. 
Summary 
The purpose of this systematic review was to explore the evidence-based strategies that 
can aid in increasing medication adherence in mentally ill patients. This section has provided a 
detailed overview of the methods and procedures used to conduct a systematic review. The 
practice-focused question, sources of evidence, and analysis and synthesis process have been 
explicitly discussed in the section. The goal of the systematic review was to synthesize the most 
relevant and current evidence on interventions for promoting adherence to psychotropic 
medications among adults with mental health disorders. The findings of the systematic review 
were used to provide recommendations for positive change in practice to reduce the rate of 
nonadherence to psychotropic medications. Section 4 provides a comprehensive discussion of the 
findings of the systematic review, together with the recommendations. I also present the 




Section 4: Findings and Recommendations 
Introduction 
Despite the effectiveness of antipsychotics in the management of mental disorders, many 
patients still fail to maintain optimal adherence (Montejo et al., 2018). It is estimated that the rate 
of medication nonadherence among patients with mental health disorders could reach 70% 
(Chakrabarti, 2016). Given that mental health disorders affect about 47 million Americans 
annually and the high cost of managing depression, there is a need to adopt more effective 
interventions to improve adherence in this population (SAHMSA, 2017). These figures highlight 
the extent of nonadherence to prescribed treatment regimen aimed at managing psychotic 
symptoms among patients with mental health illnesses. Harrison et al. (2019) indicated that 
adherence to psychotropic medication is challenging and continues to worsen in the United 
States. Nonadherence has been linked to high suicide risk, deterioration, rehospitalization, and 
low quality of life (Borba et al., 2018). Thus, there is a need for psychiatric clinicians to design 
and adopt more effective interventions to improve adherence to psychotropic medications in 
mental health patients. The problem addressed in this systematic review was the high rate of 
nonadherence among individuals with SPMI. There is also inadequate literature on the most 
effective strategies for improving adherence among individuals with mental health disorders. 
The purpose of this systematic review was to explore the evidence-based strategies that 
can aid in increasing medication adherence in mentally ill patients. This section provides a 
detailed discussion of the findings and implications of the systematic review, its strengths and 
implications, and recommendations based on the findings. The sources of evidence included 




EBSCOHost, and Joanna Briggs Institute. The systematic review was conducted using the 
PRISMA strategy.   
Findings and Implications 
For this project I employed systematic review to examine and analyze studies conducted 
between 2015 and 2019, recording a total of 15,092 journal articles, reduced to 13,540 after the 
duplicates were removed. However, 110 counted for eligibility, and 102 were excluded because 
they did not meet the inclusion criteria. The key terms used for the journal article search included 
medication adherence, antipsychotics, and medical interventions. This DNP project did not 
involve human subjects; however, it adheres to rules and regulations set forth by Walden 
University and the IRB. The project, therefore, aligned with the requirements of Walden 
University Manual for Systematic Review and may enhance nurses, and the organization in 
promoting medication adherence.   
The PRISMA flow diagram (see Figure 2) presents important information pertaining to 
procedural steps that were utilized for this DNP project in terms of screening, identification, 






























Figure 2. PRISMA flow diagram 
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Summary Table of Analyzed Articles 
Citation Main findings Research method Strengths 
 
Weakness  Level of 
Evidence    
Blixen, C., Sajatovic,  
M., Moore, D. J., 
 Depp, C., Cushman, 
C., Cage, J., … Levin, 
 J. B. (2018). Patient 
participation in the 




adherence in poorly 
adherent individuals 
with bipolar disorder 
(BD) and 
Hypertension (HTN). 
International Journal  
of Healthcare, 4(1),  
25–35.  
Bixen (2018) study aimed  
at gathering information  
that would be useful in 
developing an intervention 
for client identification 
who did not demonstrate 
medical adherence  
Findings included: 
Forgetfulness as the most 
frequent barrier to taking 
antihypertensive 
medications. Decisions 
about taking medications 
are influenced by BD 
mood fluctuations and the 
burden of having to take 
“too many pills” for the 
illnesses. There was 
positive feedback on the 
use of a text-messaging 
system to help with 
medication adherence for 
BD and HTN. 
Qualitative methods 
were used to obtain 
information. A 
purposeful sampling of 
30 participants was 
invited via telephone 13 
focus group consented.  
Focus groups of 3 – 5 
were conducted 
debriefings were 
audiotaped and later 
transcribed by an expert.  
Data collected was 
tranquilized by 
comparing focus group 
sessions discussion and 
noted collected by an 
observer.  




from the participants 
using text messages. 
Furthermore, the high 
presentation of  
African Americans 
will be considered a 
strength for the study 
because they are very 
scarce studies using 
African Americans as 
the highest number of 
participants in the 
given study. 
There was an 
indication of 
weakness in the 
study in terms of 







 Level IV 
El-Mallakh, P., & 
Findlay, J. (2015). 
Strategies to improve 
medication adherence 
in patients with 
schizophrenia: The role 
of support services. 
Neuropsychiatric 
Disease and  
Treatment, 11, 1077-
1090. 
It is recommended that 
prescribers should educate 
patients on the importance 
of adherence to psychiatric 
medications as a priority 
and then address adherence 
to medications for medical 
illnesses as a secondary 
goal since PWS have 
reported that stable 
psychiatric symptoms are 
an essential precursor to 
the effective management 
of medical illnesses. 
Literature review of 22 
studies. 
An improvement in the 
positive symptom 
rating subscale of the 
Positive and Negative 
Syndrome Scale was 
the strongest predictor 
of treatment 
adherence, regardless 




adherence due to 
financial constraints 
and affordability of 
medications were 
not addressed in 
these studies, which 
is a noteworthy gap 
that warrants further 
research. 
  Level V 
Kreyenbuhl, J., 
Record, E. J., & 
Palmer-Bacon, J. 




adherence in serious 
mental 







Novel technologies for 
improving adherence are 
being developed and have 
undergone preliminary 
feasibility testing. 
mHealth applications and 
text messaging are 
effective in changing 
health behaviors, including 
medication adherence, as 
well as improving clinical 
outcomes for a number of 
nonpsychiatric medical 
conditions. mHealth AEIs 
seem helpful in people for 
whom nonadherence is 
unintentional, that is, 







utilizing the platforms 
have the potential for 
widespread 
dissemination to a 
broad range of 
individuals with 
serious mental illness. 
Mobile phones, in 
particular are relatively 
low cost and have the 
potential for replacing 
face-to-face contact 
with health care 
professionals. 
Experience is more 
limited in mHealth 
applications 
involving mobile 















Citation Main findings Research method Strengths 
 
Weakness  Level of 
Evidence    
      
Montejo, A. L., 
Montejo, L., & 
Baldwin, D. S. (2018). 
The impact of severe 
mental disorders and 
psychotropic 
medications on sexual 







Sexual dysfunction is 
common during short‐and 
long‐term treatment with 
antipsychotics. It is 
associated with an impact 
on the quality of life in 
adult and adolescent 
patients. Erectile problems 
with antipsychotic drugs 
are related to endothelial 
dysfunction linked to 
decreased nitric oxide 
production. Depressive 
symptoms are associated 
with sexual difficulties and 
dissatisfaction. Patients 
with bipolar disorder tend 
to have more stable sexual 
partners and more intense 




Treatments with fewer 
adverse sexual effects 
should be considered 
as potential first‐line 
options in patients with 
severe mental illness 
interested in 
maintaining a sexual 
life. 
It seems difficult to 
perform systematic 
inquiries in all 
patients about 
previous and 
current sexual life 
needed to assess 
potential sexual 
dysfunction. 
There is little 








Moran, K., & Priebe, 
S. (2016). Better 
quality of life in 
patients offered 
financial incentives for 
taking anti-psychotic 
medication: Linked to 
improved adherence or 
more money? Quality 




medication adherence was 
found to be a significant 
predictor of better 
subjective quality of life 
whilst the amount of 
incentives received was 
not. 
Improved medication 
adherence is associated 




A secondary analysis 
was performed using 
data of the experimental 
group in the trial. 
Regression models. 
Use of audits to ensure 
correct data is 
analyzed. 
There was no 






Pauly, A., Wolf, C., 
Mayr, A., Lenz, B., 
Kornhuber, J., & 
Friedland, K. (2015). 
Effect of a multi-
dimensional and inter-
sectoral intervention on 
the adherence of 
psychiatric patients. 


















Adherence in psychiatric 
patients is strongly 
affected by their attitude 
towards their medication. 
Increasing age contributes 
to a more adherent 
behavior until a threshold 
of about 75 years when 
forgetfulness and frailty 
impede adherence. 
 
Two hundred sixty-nine 
patients from a German 
university hospital were 
included in a 
prospective, open, 
clinical trial with 
consecutive control and 
intervention groups 269 
patients from a German 
university hospital were 
included in a 
prospective, open, 
clinical trial with 
consecutive control and 
intervention groups. 
It was determined that 
the implementation of 
a multi-dimensional 
and inter-sectoral 
program enhances the 
patients’ adherence 
significantly up to 




report is an indirect 
and subjective 
approach, and thus 
a less valid way of 
measuring 
adherence 







and lead to a 
possible over- as 
well as under-
estimation of the 
intervention’s effect 
size. The study time 
was too short for 
measuring relapse 
and subsequent 









Citation Main findings Research method Strength Weakness Level of 
Evidence 
Rolving, N., Brocki, B. 
C., Mikkelsen, H. R., 
Ravn, P., Bloch-
Nielsen, J. R., & Frost, 
L. (2017). Does an 8-
week home-based 
exercise program affect 
physical capacity, 
quality of life, sick 
leave, and use of 
psychotropic drugs in 
patients with 
pulmonary embolism? 
Study protocol for a 
multicenter 
randomized clinical 
trial. Trials, 18(1), 245.  
A home-based exercise 
program improves the 
physical capacity and 
quality of life for the 







investigating the effect 
of a low-cost home-
based exercise program 















Steinkamp, J. M., 
Goldblatt, N., 
Borodovsky, J. T., 
LaVertu, A., Kronish, 





in adult mental health 
and substance use 
disorders: A systematic 
review. Journal of 
Medical Internet 
Research Mental 
Health, 6(3), e12493. 
doi:10.2196/12493 
Despite the differences in 
the mental state between 
different disorders, and 
perhaps even different 
primary reasons for 
nonadherence, there is still 
much to be learned and 
transferred from one 
domain to the others.  
The most commonly 
studied method for 
measuring medication 





management apps, have 
been studied in the 
majority of psychiatric 
disorders. 
 
A systematic scoping 
review of technological 
interventions designed 
to improve medication 
adherence in mental 
health and substance use 
populations 
Qualitative synthesis of 
themes in the literature. 
The strengths of our 
study included the 
breadth of the topic 
area and the 
comprehensive 
coverage of all types 
of interventions, as 











interventions across all 
adult mental health and 
substance use 
disorders. 
The study was 
limited by this 
breadth; 
researchers were 




analysis of all 
included studies 









All selected articles were critically evaluated by examining each study, goals, design, 
methodology, results, sample size, and conclusions. I consulted the chair to ensure reliability and 
validity. All of the selected studies indicated evidence-based interventions that are employed to 
improve medication adherence among individuals with mental health issues. Three studies 
addressed the effectiveness of financial incentives (El-Mallakh & Findlay, 2015; Kreyenbuhl et 
al., 2016; Moran & Priebe, 2016). In addition to financial incentives, Kondo et al. (2015) 




cost-sharing. Five studies addressed technological interventions for improving medication 
adherence (Blixen et al., 2018; Kondo et al., 2015; Kreyenbuhl et al., 2016; Steinkamp et al., 
2019). Only two studies evaluated the effectiveness of non-technological behavioral 
interventions (Kreyenbuhl et al., 2016; Pauly et al., 2015). In addition, one study addressed the 
use of a home-based physical exercise program to improve medication adherence (Rolving et al., 
2017).  
El-Mallakh and Findlay (2015) found that interventions that incorporate support services 
should be adopted to help in addressing special needs among mental health patients. Similarly, 
Kreyenbuhl et al. (2016) recommended the adoption of effective cognitive-behavioral 
interventions to improve medication compliance. Moran and Priebe (2016) indicated that 
improving medication compliance among mental health patients would enhance their quality of 
life. Kondo et al. (2015) recommended the adoption of psychosocial and behavioral 
interventions, including motivational interviewing, shared decision-making, compliance 
therapies, customized adherence enhancement, and cognitive-behavioral therapy. Rolving et al. 
(2017) found that physical exercise programs can improve adherence to psychotropic 
medication, patients’ quality of life, and physical capacity.   
Data Analysis 
A descriptive statistical analysis approach was utilized to statistically analyze this 
doctoral project specifically to analyze studies conducted between 2015 and 2019. Analysis of 
the selected articles was conducted using quantities approaches. Initially, I read all the referenced 
articles. Although all the articles had been searched with the keywords and retrieved from 




methodological. For instance, those articles had frequent and thorough descriptions of how 
patients fail to adhere to medication, never followed through with the health care providers 
especially after discharge from the hospital, and while in other environments including nursing 
homes, or under care and supervision of family members as well as on their own personal 
setting. After that, I independently assessed the methodological quality using a systematic review 
approach. For instance, in each study, I counted the number of times/frequencies of specific 
parameters that included the following: mental health, medication adherence, and interventions 
were mentioned. The findings of this present DNP analysis were tabulated and are presented in 















Articles Hospital Nursing home Family care Personal setting                 Total 





























✔ ✔ ✔ ✔ ✔    ✔  ✔ ✔ 8 
Kreyenbuhl, 
Record, &  
Palmer-Bacon 
(2016). 
✔ ✔ ✔ ✔   ✔   ✔   6 
Moran & Priebe 
(2016). 














✔ ✔ ✔ ✔ ✔   ✔     6 
Steinkamp et al.  
(2019).  
✔ ✔ ✔   ✔       4 
Total number 






7 6 7 5 3 2 3 2 2 2 1 1 41 





I employed both qualitative and quantitative approaches to interpreting findings. The 
overall number frequencies were based on the total number of each factor that was mentioned in 
the method, results, and discussion of the journal articles. In general, the total number of 
frequencies was 41. The results revealed that the majority of patients could demonstrate 
medication adherence as a result of interventions and could significantly affect positive 
improvement in their quality of life. Four out of the eight articles yield higher frequencies 
compared to other articles. Those specific articles (Blixen, et al., 2018; Kondo et al., 2017; 
Kreyenbuhl et al., 2016; Rolving et al., 2017) presented thorough descriptions of factors 
analyzed when compared to other studies. On the other hand, limited intervention frequencies 
based on low raw scores were documented under family care and personal settings (Pauly et al., 
2015; Steinkamp, et al., 2019). Arguably, these findings indicated the need for health care staff 
to establish more collaboration approaches that could support mental health patients’ medical 
adherence while working with family members, or on their own.  
Numerous studies regarding this study were conducted by (El-Mallakh & Findlay, 2015; 
Kreyenbuhl et al., 2016; Montejo et al., 2018; Moran & Priebe, 2016; Rolving et al., 2017; 
Steinkamp et al., 2019) in different settings. However, their general goal was the advocacy for 
mental health patients in terms of medication adherence and innovative approaches, including 
interventions that can potentially motivate mental health patients to adhere to medication and 
improve their quality of life. Steinkamp et al.’s (2019) qualitative study targeted at populating a 
comprehensive framework by generating themes from the literature review, and the results were 




components understudy into interventions, medication adherence, mental health, and substance 
use populations. In support, Kreyenbuhl et al. (2016) pointed out the need for health care 
workers to emphasize and stress medication adherence after patient discharge. Kreyenbuhl et al. 
also advocated for innovative approaches such as integrating electronic technology monitors and 
mobile phones to monitor and strengthen compliance policies in support of patient’s medication 
adherence. Recent studies (Montejo et al., 2018.) postulate that management of mental health 
treatment offsite the hospital setting is indeed crucial.  
  Furthermore, Rolving et al. (2017) advocated for a home care program that could vitally 
enhance the physical ability and quality of life among mental health patients. Other studies 
examined for this study attest that home visit programs with a well-designed schedule, providing 
daily living skills training, could enable mental health patients to follow through with health care 
providers and thus medication adherence (El-Mallakh & Findlay, 2015). Also, Moran and Priebe 
(2016) linked good adherence to antipsychotic medication. 
Unanticipated limitations/outcomes. A primary limitation of the systematic review was 
the use of a single reviewer, which limited the number and rigor of the review process. The 
inclusion of more reviewers would facilitate in-depth and more extensive evidence appraisal. In 
addition to the time-consuming, nature of systematic review, investigators may also experience 
various difficulties in combining studies when conducting systematic reviews. Another limitation 
of the systematic review is that the selected studies employed different designs, thus making it 
challenging to combine the findings. In addition, the review process yielded a limited sample of 




Implications from Findings  
The findings of this systematic review have a significant impact on individuals with 
mental health disorders, communities, psychiatric institutions, and the healthcare system in 
general. For example, mental health patients can apply knowledge from this systematic review to 
select the most effective evidence-based interventions for improving adherence to psychotropic 
medications. Also, psychiatric clinicians apply the findings to design interventions that meet the 
specific needs of individual mental health patients. Enhanced awareness of evidence-based 
strategies for improving adherence to psychotropic medications can significantly benefit 
patients’ family members and the community in general. For instance, clinicians can design 
specific interventions for individual populations, depending on their needs. The current 
systematic review can also be used by psychiatric institutions as a reference when designing 
interventions for improving adherence to psychotropic medications.  
 Also, the findings have significant implications for positive social change in psychiatric 
care in the United States. Increased awareness of evidence-based interventions for medication 
adherence can be translated into practice to improve health outcomes among this population. 
Improvement of health outcomes among mental health patients can result in a reduction in 
healthcare costs and the rate of readmission. 
Recommendations 
Based on the comprehensive literature review, the selected articles identified various 
studies that indicated the effectiveness of evidence-based interventions for improving mental 
health patients’ adherence to psychotropic medications. A recommendation for psychiatric 




technological interventions for improving medication adherence among patients with mental 
illnesses. In addition, more qualitative studies involving interviews or focus groups should be 
conducted to understand patients’ perceptions and attitudes regarding specific evidence-based 
interventions for improving adherence to psychotropic medications.  
Strengths and Limitations of the Project 
 A primary strength of the systematic review was the use of a systematic review design, 
which allowed for the usage of detailed inclusion-exclusion criteria. Systematic reviews also 
facilitate a comprehensive and exhaustive study of current, ongoing, and unpublished literature 
to address a given problem (Selcuk, 2019). Findings from systematic reviews can also be 
generalized to broader populations; thus, it can be used as reliable and accurate sources of 
evidence (Robinson & Lowe, 2015). The systematic review also employed the HBM and Iowa 
models that allowed the application of concepts, including perceived self-efficacy and usefulness 
of the evidence-based strategies for improving medication adherence. Another strength of this 
systematic review is that the knowledge, skills, and evidence that I gained throughout the process 
are transferrable into practice.  
In relation to the methodologies, there is still a need for more qualitative studies to 
explore mental health patients’ perceptions of the most effective evidence-based interventions 
for improving adherence to psychotropic medications. An in-depth understanding of patients’ 
preferences, needs, and attitudes regarding specific interventions can aid in enhancing adherence 
because of improved willingness. Thus, future studies need to incorporate qualitative approaches, 
including face-to-face interviews, focus groups, and case studies to address the existing gap in 




Section 5: Dissemination Plan 
Introduction 
The current systematic review provided an opportunity for psychiatric nurses to 
understand the various evidence-based interventions for improving medication adherence among 
mental health patients. Thus, the dissemination of the findings can play an essential role in 
addressing the knowledge gap and facilitating the translation of evidence into practice. This 
section provides a comprehensive overview of how the systematic review findings were 
disseminated and the analysis of self in different professional roles.  
Dissemination of Findings 
The primary audience for the dissemination of the systematic review includes psychiatric 
clinicians, nurse managers, and adult mental health patients. A practical method for 
disseminating the findings of the systematic review is the development of a manuscript that was 
published in nursing journals and websites of psychiatric facilities. The manuscript can also be 
presented in future conferences and workshops. I also developed a poster and PowerPoint 
presentation that will be made available to psychiatric clinicians. The advantage of developing 
posters and PowerPoints presentations is that they can be presented to wide audiences in open 
forums. Because of the nature of the systematic review, the ideal audience is psychiatric nurses, 
physicians, and associated health care providers. The potential avenue of dissemination of this 
evidence-based systematic review is by conferences, workshops, and manuscripts that include 
journals such as the Journal of Psychiatric Research and The American Journal of Psychiatry. 
The available resources will be compiled together in a mini folder and be made available at the 




Analysis of Self 
My doctoral journey and the process of developing this systematic review has equipped 
me with immense knowledge and skills necessary to succeed in my practice area. First, the DNP 
project has strengthened me with leadership skills as a project leader and facilitator. As a project 
manager, I was able to enhance my planning and resource management skills by ensuring all 
project deliverables were met. I planned and executed every part of the project within the 
scheduled timeframe. As a nurse practitioner, I used knowledge from the DNP program to design 
the systematic review and conduct a comprehensive systematic review to identify the most 
effective interventions for improving medication adherence. Nurses who work in complex 
settings have the responsibility of identifying gaps in practice and designing or recommending 
effective interventions. 
As a scholar, the systematic review strengthened my research, data collection, and 
analytical skills as I was able to access different libraries and appraised relevant studies. The 
primary goal of the systematic review was to address the gap in knowledge on evidence-based 
strategies for improving adherence to psychotropic medications. My educational background as a 
scholar prepared me adequately for the data collection, systematic review, and evaluation 
processes. One challenge I experienced was the limited number of studies evaluating the 
effectiveness of specific interventions for improving adherence to psychotropic or antipsychotic 
medications. There is a lack of practice guidelines regarding the implementation of evidence-






The purpose of this systematic review was to explore the evidence-based strategies that 
can aid in increasing medication adherence in mentally ill patients. The target problem was the 
lack of adequate evidence of effective interventions for improving mental health patients’ 
adherence to psychotropic medications. The systematic review yielded various interventions 
focused at patients, psychiatric clinicians and family members, and other health care 
professionals. The systematic review yielded eight studies that have addressed evidence-based 
strategies targeted at patients, psychiatric clinicians, and systems. Specifically, the studies 
addressed interventions such as financial incentives, care coordination, blister packaging, and 
cost-sharing. Also, the studies evaluated technological interventions and a home-based physical 
exercise program. The systematic review is an essential addition to existing evidence on effective 
strategies for improving medication adherence among individuals with mental health issues. 
However, there is a need for further qualitative studies to address patients’ preferences of the 
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